Výsledky vyhledávání - "Ida Contasta"

Akademický článek

Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer

Autor: Patrizia Pellegrini, Ida Contasta, Tiziana Del Beato, Fabiana Ciccone, Anna Maria Berghella

Publikováno v: Clinical and Developmental Immunology, Vol 2011 (2011)

Studies focusing on gender have shown that differences exist in how the immune system responds to disease and therapy. Understanding how gender influences immunological mechanisms in health and disease and identifying gender-specific biomarkers could

Externí odkaz: https://doaj.org/article/e2fa33ad289a46f7ad59a019e6a293d2

Zobrazit plný text záznamu

The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender- specific Biomarkers in Personalized Cancer Therapy

Autor: Tiziana Del Beato, Luigi Liborio Liberatore, Ida Contasta, Anna Maria Berghella, Antonio Mongelli, Enzo Secinaro, Irma Campitelli, Giancarlo Di Gregorio, Matteo Basta, Fabiana Ciccone, Mauro Domenicucci, Patrizia Pellegrini, Roberto Lattanzio, Nunzia Antonucci, Vincenzo Vittorini, Luca Navarra, Giampaolo Caterino, Marino Silvino

Publikováno v: Current drug targets
18 (2017): 485–495. doi:10.2174/1389450117666160630173647
info:cnr-pdr/source/autori:Berghella, Anna Maria; Contasta, Ida; Lattanzio, Roberto; Di Gregorio, Giancarlo; Campitelli, Irma; Silvino, Marino; Liberatore, Luigi Liborio; Navarra, Luca; Caterino, Giampaolo; Mongelli, Antonio; Vittorini, Vincenzo; Basta, Matteo; Domenicucci, Mauro; Antonucci, Nunzia; Del Beato, Tiziana; Secinaro, Enzo; Ciccone, Fabiana; and Pellegrini, Patrizia/titolo:The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender-specific Biomarkers in Personalized Cancer Therapy/doi:10.2174%2F1389450117666160630173647/rivista:Current drug targets (Print)/anno:2017/pagina_da:485/pagina_a:495/intervallo_pagine:485–495/volume:18

The definition of personalized treatments in tumor disease could lead to an improvement of the therapeutic success rate. Therefore, biomarkers are urgently required in order to select the patients that could benefit from adjuvant therapies in the ini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dbfb65ad8863dc1218159fb65428af5
https://doi.org/10.2174/1389450117666160630173647

Zobrazit plný text záznamu

Day of Immunology 2015

Autor: Anna Maria Berghella, Ida Contasta, Giuseppe Marulli, Carlo D'Innocenzo, Ferdinando Garofalo, Francesca Gizzi, Marco Bartolomucci, Giacomo Laglia, Marisa Valeri, Mario Gizzi, Mauro Friscioni, Mario Barone, Tiziana Del Beato, Enzo Secinaro, Patrizia Pellegrini

Publikováno v: Immunity & ageing (2016). doi:10.1186/1742-4933-11-3
info:cnr-pdr/source/autori:Anna Maria Berghella, Ida Contasta, Giuseppe Marulli, Carlo D'Innocenzo, Ferdinando Garofalo, Francesca Gizzi, Marco Bartolomucci, Giacomo Laglia, Marisa Valeri, Mario Gizzi, Mauro Friscioni, Mario Barone, Tiziana Del Beato, Enzo Secinaro and Patrizia Pellegrini/titolo:Day of Immunology 2015/doi:10.1186%2F1742-4933-11-3/rivista:Immunity & ageing/anno:2016/pagina_da:/pagina_a:/intervallo_pagine:/volume

Low-grade inflammatory state causes the development of the principal chronic-degenerative pathologies related with ageing. Consequently, it is required a better comprehension of the physiologic origins and the consequences of the low-grade inflammato

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::385d8666111d57818bf4e4d7184f322f

Zobrazit plný text záznamu

Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer

Autor: Tiziana Del Beato, Anna Maria Berghella, Fabiana Ciccone, Ida Contasta, Patrizia Pellegrini

Publikováno v: Clinical and Developmental Immunology, Vol 2011 (2011)
Clinical and Developmental Immunology
Clinical & developmental immunology
1 (2011): 16.
info:cnr-pdr/source/autori:Patrizia Pellegrini, Ida Contasta, Tiziana Del Beato, Fabiana Ciccone, and Anna Maria Berghella./titolo:Gender-Specific Cytokine Pathways, Targets, and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer./doi:/rivista:Clinical & developmental immunology (Print)/anno:2011/pagina_da:16/pagina_a:/intervallo_pagine:16/volume:1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0417446b03819a0af878b4711c1658e1
https://doi.org/10.1155/2011/819724

Zobrazit plný text záznamu

The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy

Autor: Fabiana Ciccone, Patrizia Pellegrini, Tiziana Del Beato, Ida Contasta, Anna Maria Berghella

Publikováno v: Cancer Immunology, Immunotherapy

Our progress in understanding pathological disease mechanisms has led to the identification of biomarkers that have had a considerable impact on clinical practice. It is hoped that the move from generalized to stratified approaches, with the grouping

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bfb3f45bc9a9e307ddf3bdb512692c7
http://europepmc.org/articles/PMC3176405

Zobrazit plný text záznamu

Soluble CD30: A Biomarker for Evaluating the Clinical Risk versus Benefit of IFNβ1A Treatment in Multiple Sclerosis Patients

Autor: A-M. Berghella, P. Pellegrini, T. Del Beato, Rocco Totaro, Antonio Carolei, Ida Contasta, Domenico Adorno

Publikováno v: Europe PubMed Central
International journal of immunopathology and pharmacology 23 (2010): 213–226.
info:cnr-pdr/source/autori:CONTASTA I; TOTARO R1; BERGHELLA AM; PELLEGRINI P; DEL BEATO T; CAROLEI A1; ADORNO D/titolo:Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients./doi:/rivista:International journal of immunopathology and pharmacology/anno:2010/pagina_da:213/pagina_a:226/intervallo_pagine:213–226/volume:23
Scopus-Elsevier

Aberrant redox regulation occurs in immune and neurological pathologies, hence targeting the pathways involved in the regulation of the redox system could provide further insights into these diseases and open up new avenues for therapy. Soluble (s) C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1e6e0a81f255c75b0f66387d70bde1c
https://doi.org/10.1177/039463201002300119

Zobrazit plný text záznamu

CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response

Autor: Ida Contasta, Domenico Adorno, Patrizia Pellegrini, Anna Maria Berghella

Publikováno v: Transplant Immunology. 12:49-61

Understanding the physiological role of CD30 would be an important step forward in transplants because CD30+ T cells can be induced by alloantigens even in the presence of immunosuppressives such as cyclosporine (Csa) and hence can act as regulatory

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9625b17062507bf85d06a652c39ff157
https://doi.org/10.1016/s0966-3274(03)00014-5

Zobrazit plný text záznamu

Novel Prognostic Biomarkers for Personalized Cancer Treatment

Autor: Antonio Mongelli, Giampaolo Caterino, Maurizio Vizioli, Osvaldo Ciccarelli, Ida Contasta, P. Pellegrini, Enzo Secinaro, Marino Silvino, Tiziana Del Beato, Roberto Lattanzio, Luca Navarra, Luigi Liborio Liberatore, Irma Campitelli, Giancarlo Di Gregorio, Anna Maria Berghella, Nunzia Antonucci, Vincenzo Vittorini

Publikováno v: Cancer Immunology ISBN: 9783662449455
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers, edited by Nima Rezaei, pp. 35–54. Berlin Heidelberg: Springer, 2015
info:cnr-pdr/source/autori:CONTASTA IDA 2, BERGHELLA ANNA MARIA 2, LATTANZIO ROBERTO 3, CICCARELLI OSVALDO 3, DI GREGORIO GIANCARLO 4, VIZIOLI MAURIZIO 5, SILVINO MARINO 6, LIBERATORE LUIGI LIBORIO 3, NAVARRA LUCA 3, CATERINO GIAMPAOL 3, MONGELLI ANTONIO 3, VITTORINI VINCENZO 3, CAMPITELLI IRMA 4, NUNZIA ANTONUCCI 3, DEL BEATO TIZIANA 2, SECINARO ENZO 7 AND PELLEGRINI PATRIZIA 2/titolo:Novel Prognostic Biomarkers for Personalized Cancer Treatment/titolo_volume:Cancer Immunology: Bench to Bedside Immunotherapy of Cancers/curatori_volume:Nima Rezaei/editore: /anno:2015

Neoplastic pathologies are one of the most frequent cause of death in the world and, in spite of the treatment's improvement, the related mortality of tumour is high. One of the principal cause of this situation is the lack of clinical prognostic bio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9788b660b8efef7249b00af1b61ea8e9
https://doi.org/10.1007/978-3-662-44946-2_3

Zobrazit plný text záznamu

Cell Cycle Control in Cellular Homeostasis During the Immune Response: Interactions Between TH1, TH2 Cytokines, and Bcl2 and p53 Molecules

Autor: Patrizia Pellegrini, Domenico Adorno, Anna Maria Berghella, Ida Contasta

Publikováno v: Cancer biotherapy & radiopharmaceuticals 16 (2001): 63–71.
info:cnr-pdr/source/autori:Contasta I., Pellegrini P., Berghella AM., Adorno D./titolo:Cell cycle control in cellular homeostasis during the immune response: interactions between TH1, TH2 cytokines, and Bcl2 and p53 molecules/doi:/rivista:Cancer biotherapy & radiopharmaceuticals/anno:2001/pagina_da:63/pagina_a:71/intervallo_pagine:63–71/volume:16

Cytokine regulation of lymphocyte survival may play an important role in the control of the cell cycle during the immune response both in health and disease. Expression of the Bcl2 gene promotes cell survival by countering apoptosis stimuli. The p53

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa75bfcef5423c4123a9f15ce84757f3
https://doi.org/10.1089/108497801750096069

Zobrazit plný text záznamu

Autor: Tiziana Del Beato, Patrizia Pellegrini, Rocco Totaro, Ida Contasta, Antonio Carolei, Anna Maria Berghella

Publikováno v: Journal of Translational Medicine
Journal of Translational Medicine, Vol 10, Iss 1, p 223 (2012)
Journal of translational medicine (Online) 10 (2012): 23. doi:10.1186/1479-5876-10-223
info:cnr-pdr/source/autori:CONTASTA I, TOTARO R, PELLEGRINI P, DEL BEATO T, BERGHELLA AM/titolo:A gender-related action of IFNß-therapy was found in multiple sclerosis./doi:10.1186%2F1479-5876-10-223/rivista:Journal of translational medicine (Online)/anno:2012/pagina_da:23/pagina_a:/intervallo_pagine:23/volume:10

Background Understanding how sexual dimorphism affects the physiological and pathological responses of the immune system is of considerable clinical importance and could lead to new approaches in therapy. Sexual dimorphism has already been noted as a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d37f119e83c123e21f3455d6948345
https://pubmed.ncbi.nlm.nih.gov/23148845

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání